Jodi Devlin insider trades
Open-market stock purchases and sales by Jodi Devlin, Chief of Clinical Operations at TriSalus Life Sciences, Inc, from SEC Form 4 filings since Aug 30, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 16, 2026 | TLSI TriSalus Life Sciences, Inc | Sold | $1.1K |
| Mar 12, 2026 | TLSI TriSalus Life Sciences, Inc | Sold | $7.2K |
| Mar 11, 2026 | TLSI TriSalus Life Sciences, Inc | Sold | $4.8K |
| Nov 24, 2025 | TLSI TriSalus Life Sciences, Inc | Bought (not open market) | — |
| Nov 24, 2025 | TLSI TriSalus Life Sciences, Inc | Bought (not open market) | — |
Companies traded
- TLSI TriSalus Life Sciences, Inc: 4 sales, last Mar 16, 2026